A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia

Abstract

The significant global presence of atypical pathogens and the better outcomes associated with antimicrobial regimens with atypical coverage support empiric therapy for all hospitalized patients with CAP with a regimen that covers atypical pathogens.